Antiviral cytotoxic T lymphocyte induction and vaccination.
about
CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis CInduction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like proteinLocal periocular vaccination protects against eye disease more effectively than systemic vaccination following primary ocular herpes simplex virus infection in rabbitsEstablishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus.Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro.Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primatesVaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccineRecognition by and in vitro induction of cytotoxic T lymphocytes against predicted epitopes of the immediate-early protein ICP27 of herpes simplex virus.Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsHerpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteinsHerpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.Immune response to bovine viral diarrhea virus induced by anti-idiotypic antibodies.Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults.Suppression of rat cytomegalovirus replication by antibodies against gamma interferon.
P2860
Q27473535-D885B796-555C-4BC2-A474-E909E1707A71Q27486239-9B8FDF57-6372-49A2-B010-41ADAB5E4A85Q33784381-283649A2-FF78-446D-8139-CF2AC52E3723Q33851211-90950B71-0ADA-46B0-A9A0-1FD2CC32F46DQ34195888-956E4ADE-5A4C-4B49-9B04-407A6A3A86C0Q35232071-0F1CB6D5-24E8-4EC0-AA8E-9E27279B0328Q36230955-49AF424F-63B9-4622-809F-3555A5A06DA5Q36249149-7D2751A8-5833-48C2-B919-2D55C4FCD7EFQ36624976-C6B16EE1-9819-4FE4-843B-2716D9F63CD2Q36625159-B0A8D855-AD6C-4C13-A0E9-A825A4647F4FQ36633526-47CF45FB-CBD8-45BE-870E-061916E03D04Q36640468-E50797F7-EDA6-4B8D-B6A3-58CEA5014A63Q36650065-D6060033-5972-434D-A1B3-31D2C5EDC432Q36695109-BDBBF9C0-325B-4B23-8EA3-83513C9E613CQ36803727-6EC4EBA8-6B19-4980-ADBD-CA075EA3F738Q36871442-E4CA277B-DDFA-4441-830C-D30C9D434050Q36873354-A60E47E6-8ABF-470E-B2DD-F7B74C2FEE4AQ36927363-A3D10525-DCC9-426D-A03D-C53C5997CF07Q37192504-ADB1B98F-9E86-49EA-A14C-B62EF35C5570Q40040075-E0E5831F-06AB-4228-9E34-8793B52662A3
P2860
Antiviral cytotoxic T lymphocyte induction and vaccination.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antiviral cytotoxic T lymphocyte induction and vaccination.
@en
type
label
Antiviral cytotoxic T lymphocyte induction and vaccination.
@en
prefLabel
Antiviral cytotoxic T lymphocyte induction and vaccination.
@en
P2093
P1476
Antiviral cytotoxic T lymphocyte induction and vaccination.
@en
P2093
P577
1988-01-01T00:00:00Z